Clinical Trials Directory

Trials / Completed

CompletedNCT02576366

Phenotypic Drug Probes as Predictors of Drug-drug Interactions With Tacrolimus

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Universitaire Ziekenhuizen KU Leuven · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Accepted

Summary

Single center, open label crossover study with 2 treatment phases in healthy volunteers. The potential of phenotypic drug probes to predict drug-drug interactions between tacrolimus, voriconazole and rifampin will be assessed.

Conditions

Interventions

TypeNameDescription
DRUGVoriconazole
DRUGRifampin

Timeline

Start date
2016-06-01
Primary completion
2017-05-01
Completion
2017-12-01
First posted
2015-10-15
Last updated
2019-08-22

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT02576366. Inclusion in this directory is not an endorsement.